FANCA and cancer: CRISPR-mediated FANCA-knockout in the lung cancer cell line models A549 and H1299 also sensitized cells to PARPi, demonstrating that FANCA deficiency induces synthetic lethality across multiple cancer types (Extended Data Fig. 1i-l).